FIELD: chemistry; medicine; pharmaceuticals.
SUBSTANCE: present invention relates to novel calicheamicin derivatives (IIA), (IIIA) and (IVA), pharmaceutical derivatives containing them, pharmaceutical compositions and combinations applicable in medicine, methods of using them in treating leukaemia and inhibiting proliferation of leukaemia cells:
or pharmaceutically acceptable salts thereof, where R3 is -CH2CH3; X is selected from -C2-C8 alkyl, optionally substituted with one R10; -(C0-C6 alkyl)-C3-C10 carbocyclyl; -(C0-C6 alkyl)-6-member heterocyclyl, wherein said 6-member heterocyclyl is optionally substituted with one R10 and said 6-member heterocyclyl contains one nitrogen heteroatom; -(C0-C6 alkyl)-phenyl, where said phenyl is optionally substituted with one R10; and -(C0-C6 alkyl)-6-member heteroaryl, wherein said 6-member heteroaryl is optionally substituted with one R10 and where said 6-member heteroaryl contains one nitrogen heteroatom; where X is optionally further substituted with 1 G; R10 is -R10a-R10b, wherein R10a is absent; R10b is selected from -CO2H; -CO2C1-C4 alkyl; -NH-R11; -CONH-R11; -CON(C1-C4 alkyl)-R11; -CONHNH-R11; R11 is -R11a-R11b-R11c, where R11a and R11b are absent; R11c is selected from a group consisting of -H and -C1-C4 alkyl; G is selected, independently for each case, from a group consisting of -NH2, -CO2H, -C1-C4 alkyl, = O and -CO2C1-C 4 alkyl; L and LR are linker fragments, AB is an antibody which binds immunospecifically to one or more antigens of the malignant cell, b equals 1–20.
EFFECT: novel calicheamicin derivatives, a pharmaceutical composition and based combinations thereof, effective for treating leukaemia.
28 cl, 50 ex, 14 tbl, 9 dwg
Title | Year | Author | Number |
---|---|---|---|
ANTIBODIES TO B7-H3 AND CONJUGATES OF ANTIBODY AND DRUG | 2017 |
|
RU2764651C2 |
3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 (IKZF2) OF THE IKAROS FAMILY | 2019 |
|
RU2797559C2 |
ANTIBODY-DRUG CONJUGATES CONTAINING HERBOXYDIENE-BASED SPLICING MODULATOR, AND METHODS OF USE THEREOF | 2019 |
|
RU2820607C2 |
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION | 2016 |
|
RU2757815C2 |
ANTIBODY AND DRUG CONJUGATES FOR DESTRUCTION OF HEMATOPOIETIC STEM CELLS | 2017 |
|
RU2781444C2 |
ANTIBODY-DRUG CONJUGATE, INTERMEDIATE FOR ITS PRODUCTION, METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2800137C1 |
ANTIBODIES AND ANTIBODY-DRUG CONJUGATES SPECIFIC TO CD123 AND THEIR USE | 2018 |
|
RU2789150C2 |
ANTIBODY-DRUG CONJUGATE TARGETING TROP2, AND METHOD FOR PREPARING AND USING SAME | 2020 |
|
RU2822663C1 |
PYRIMIDINE COMPOUND OR ITS SALT | 2020 |
|
RU2787992C1 |
COMPOSITION FOR TREATING IGF-1R EXPRESSING CANCER | 2016 |
|
RU2728568C2 |
Authors
Dates
2020-09-21—Published
2018-01-10—Filed